Featured Research

from universities, journals, and other organizations

Chronic liver cirrhosis clues: Study finds 15 new genetic signposts for primary biliary cirrhosis

Date:
March 14, 2011
Source:
Wellcome Trust Sanger Institute
Summary:
Researchers have provided new clues to the genetic causes of primary biliary cirrhosis -- a chronic form of liver disease, which leads to transplant surgery for the majority of patients. The results more than triple the number of genetic regions known to be implicated, pinpointing key immune processes that underlie susceptibility and could provide targets for the development of new therapies. The team suggests that some of the regions are also implicated in other autoimmune diseases.

Researchers have provided new clues into the genetics underlying a chronic form of liver disease, called primary biliary cirrhosis, which can lead to transplant surgery for patients. The new study identifies 15 genetic regions that affect a person's risk of developing the disease, more than trebling the number of known genetic regions, which now stands at 22.

Related Articles


The study was based on the genomes of 2,500 patients with primary biliary cirrhosis and more than 7,500 apparently healthy people. The results are the first to emerge from the Wellcome Trust Case Control Consortium 3 (WTCCC3) project, a collaboration of UK scientists and clinicians, which aims to unravel the role of genetic variation in several human diseases. The findings suggest that several key immune processes underlie susceptibility to primary biliary cirrhosis (PBC).

Patients with primary biliary cirrhosis suffer irritation and swelling of the bile ducts of the liver -- blocking the flow of bile, which normally aids digestion. The obstruction damages liver cells and leads to scarring, known as cirrhosis. Primary biliary cirrhosis is thought to affect approximately 35 out of every 100,000 adults, but that rate almost triples to 95 out of 100,000 in women over the age of 45. As there are no proven treatments available, the majority of patients will require a liver transplant.

The specific biological pathways underlying primary biliary cirrhosis are poorly understood although autoimmunity, where the body attacks its own cells, is known to play a significant role.

"To gain an insight into the causes of primary biliary cirrhosis we compared genetic data from patients and healthy volunteers and found 22 regions of the genome that differed significantly, 15 of which had not previously been identified," says Dr Carl Anderson, from the Wellcome Trust Sanger Institute and one of the senior authors on the paper. "By scrutinizing the genes within these regions we were able to identify biological pathways that appear to underpin the disease, thus prioritising these for future research and highlighting their potential for therapeutic intervention."

"This study is a key first step in our efforts to unravel the biological complexity of primary biliary cirrhosis and further research building on these results is already underway."

The team found that many of the 15 new regions contain genes involved in regulation of the immune system, with three immune pathways particularly prominent. One of these, called the NF-кB pathway, had not previously been associated with primary biliary cirrhosis although it had been implicated in other autoimmune and inflammatory diseases such as rheumatoid arthritis, multiple sclerosis and asthma. In total, five of the identified genomic regions are thought to play a role in this pathway and further work is being planned to elucidate how genetic mutations in these regions cause primary biliary cirrhosis and other related diseases.

"For clinicians involved in the management of primary biliary cirrhosis, this study is exciting because it provides new and meaningful insight into the biological origins of this condition," says Dr George Mells, from the Academic Department of Medical Genetics at the University of Cambridge and a first author on the study. "This will undoubtedly inform the development of more effective treatments, designed to target the biological pathways involved in causing the disease. The study is also a triumph of collaboration. Every NHS Trust in the UK was involved in recruitment of patients and the patient community itself was mobilised by efforts from the PBC Foundation.

"By working together, we have recruited almost one in six primary biliary cirrhosis patients in the UK; completed the largest genome-wide association study of primary biliary cirrhosis to date and established a research consortium that will form the foundation of further clinical, genetic and therapeutic studies."

This research contributes to the growing body of evidence that suggests there are many genetic risk factors that are shared between autoimmune diseases. Of the 22 regions identified in this study of primary biliary cirrhosis, 12 have previously been associated with other autoimmune disorders such as type-1 diabetes, multiple sclerosis and psoriasis. Working out how these shared pathways interact with those that, at this moment in time, appear to be unique to primary biliary cirrhosis is likely to lead to important therapeutic breakthroughs.

"The publication of this paper is no routine academic matter for people with primary biliary cirrhosis," says Collette Thain, MBE, Chief Executive of the PBC Foundation. "For us, it means hope -- one step towards understanding how best to treat and cure. It is a testament to the perseverance and ingenuity of all the scientists who worked on this project. But because this was a collaborative project, part funded by the PBC Foundation and directly involving patients, it is also an example of how people with conditions like primary biliary cirrhosis can work together with scientists and physicians to find solutions.

"As a sufferer myself, it is hard to put into words what an exciting breakthrough like this means to me and all the other people with primary biliary cirrhosis. Research like this brings a brighter tomorrow ever closer."

The research was carried out as part of the WTCCC3 project, which aims to perform genome-wide association studies in primary biliary cirrhosis, anorexia nervosa, pre-eclampsia in UK subjects, and the interactions between donor and recipient DNA related to early and late renal transplant dysfunction. The WTCCC3 will also carry out a pilot in a study of the genetics of host control of HIV-1 infection.


Story Source:

The above story is based on materials provided by Wellcome Trust Sanger Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. George F Mells, James A B Floyd, Katherine I Morley, Heather J Cordell, Christopher S Franklin, So-Youn Shin, Michael A Heneghan, James M Neuberger, Peter T Donaldson, Darren B Day, Samantha J Ducker, Agnes W Muriithi, Elizabeth F Wheater, Christopher J Hammond, Muhammad F Dawwas, David E Jones, Leena Peltonen, Graeme J Alexander, Richard N Sandford, Carl A Anderson. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nature Genetics, 2011; DOI: 10.1038/ng.789

Cite This Page:

Wellcome Trust Sanger Institute. "Chronic liver cirrhosis clues: Study finds 15 new genetic signposts for primary biliary cirrhosis." ScienceDaily. ScienceDaily, 14 March 2011. <www.sciencedaily.com/releases/2011/03/110313160028.htm>.
Wellcome Trust Sanger Institute. (2011, March 14). Chronic liver cirrhosis clues: Study finds 15 new genetic signposts for primary biliary cirrhosis. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2011/03/110313160028.htm
Wellcome Trust Sanger Institute. "Chronic liver cirrhosis clues: Study finds 15 new genetic signposts for primary biliary cirrhosis." ScienceDaily. www.sciencedaily.com/releases/2011/03/110313160028.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins